More Imexpharm Corporation news
Imexpharm CorporationHOSE: IMP

IMP: 2024 Annual Report

Jul 28, 2026 at 6:03 AM EDT · Issued by Imexpharm Corporation

Filed with HOSE · Jul 28, 2026 at 6:03 AM EDT

On 6ix: 6ix.com/news/imp-2024-annual-report

Imexpharm Corporation (IMP)

2024 Annual Report of Imexpharm Corporation as follows:

View Attachment

6ix hasn’t read this filing yet.

Imexpharm Corporation on 6ix

Story so far

  • IMP: 2023 Annual ReportJul 28, 2026
  • IMP: 2025 Annual ReportJul 28, 2026
  • IMP: Signing an audit contract for the 2026 financial statementsJun 30, 2026

Earlier from Imexpharm

  • IMP: 2023 Annual ReportJul 28
  • IMP: 2025 Annual ReportJul 28
  • IMP: Record date for 2025 cash dividend paymentJul 5
  • IMP: Notice of the record date for 2025 cash dividend paymentJul 1
  • IMP: Approval of the record date for 2025 cash dividend paymentJul 1

Later from Imexpharm

  • IMP: Report on Corporate Governance for the first half of 2026Jul 30
  • IMP: The Board resolution dated September 7, 2026Sep 7
  • IMP: Update Regulations on Supervision and Approval of related party transactionsSep 30
  • IMP: Update Regulations on the Internal AuditSep 30
  • IMP: Update Regulations on the Operation of the audit & Risk Management CommitteeSep 30
All Imexpharm news releases↗

Follow Imexpharm into a list and get an email when it puts out news.

Follow Imexpharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer